A. Total (n = 1982) | Willing to be vaccinated | OR (95% CI) | aOR (95% CI) | |||
Yes = 1447 | No = 539 | |||||
Variables | n (%) | n (%) | ||||
Spoken to HCP about vaccine during perinatal period | 835 (57.7) | 268 (49.7) | 1.38 (1.13–1.68) | 1.67 (1.32–2.12) | ||
Beliefs: I have a good understanding of how the COVID-19 vaccine works | 1077 (74.4) | 328 (60.9) | 1.87 (1.52–2.31) | 0.89 (0.69–1.15) | ||
Beliefs: COVID-19 vaccine is effective | 1275 (88.1) | 325 (60.3) | 4.88 (3.86–6.17) | 3.56 (2.70–4.69) | ||
Worries: May lead to infertility | 188 (13.0) | 211 (39.2) | 0.23 (0.18–0.29) | 0.66 (0.49–0.88) | ||
Worries: May lead to pregnancy loss or stillbirth | 398 (27.5) | 302 (56.0) | 0.30 (0.24–0.37) | 0.85 (0.65–1.13) | ||
Worries: May lead to fetal growth and development problems | 527 (36.4) | 411 (76.3) | 0.18 (0.14–0.22) | 0.33 (0.24–0.46) | ||
Worries: Child behavioural neurodevelopmental problems | 409 (28.2) | 336 (62.3) | 0.24 (0.19–0.29) | 0.64 (0.48–0.84) | ||
Date of survey completiona | 0.98 (0.98–0.98) | 0.99 (0.98–0.99) | ||||
B. Pre-conception (n = 254) | Willing to be vaccinated | OR (95% CI) | aOR (95% CI) | |||
Yes = 171 | No = 83 | |||||
Variables | n (%) | n (%) | ||||
Spoken to HCP about vaccine during perinatal period | 59 (34.5) | 27 (32.5) | 1.10 (0.63–1.91) | 1.44 (0.75–2.74) | ||
Beliefs: I have a good understanding of how the COVID-19 vaccine works | 119 (69.6) | 47 (56.6) | 1.75 (1.02–3.02) | 0.83 (0.43–1.58) | ||
Beliefs: COVID-19 vaccine is effective | 146 (85.4) | 46 (55.4) | 4.70 (2.56–8.61) | 3.48 (1.76–6.88) | ||
Worries: May lead to infertility | 65 (38.0) | 62 (74.7) | 0.21 (0.12–0.37) | 0.45 (0.22–0.93) | ||
Worries: May lead to pregnancy loss or stillbirth | 94 (55.0) | 69 (83.1) | 0.25 (0.13–0.47) | 0.50 (0.21–1.20) | ||
Worries: May lead to fetal growth and development problems | 108 (63.2) | 73 (88.0) | 0.24 (0.11–0.49) | 0.50 (0.18–1.38) | ||
Worries: Child behavioural neurodevelopmental problems | 85 (49.7) | 58 (69.9) | 0.43 (0.24–0.74) | 1.07 (0.49–2.35) | ||
Date of survey completion | 0.98 (0.97–0.99) | 0.99 (0.98–1.01) | ||||
C. Pregnancy (n = 1062) | Willing to be vaccinated | OR (95% CI) | aOR (95% CI) | |||
Yes = 716 | No = 346 | |||||
Variables | n (%) | n (%) | ||||
Spoken to HCP about vaccine during perinatal period | 592 (82.7) | 210 (60.7) | 3.09 (2.31–4.13) | 3.34 (2.39–4.67) | ||
Beliefs: I have a good understanding of how the COVID-19 vaccine works | 533 (74.4) | 220 (63.6) | 1.67 (1.27–2.20) | 0.84 (0.60–1.13) | ||
Beliefs: COVID-19 vaccine is effective | 636 (88.8) | 226 (65.3) | 4.22 (3.06–5.82) | 2.79 (1.19–4.06) | ||
Worries: May lead to infertility | 62 (8.7) | 100 (28.9) | 0.233 (0.16–0.33) | 0.55 (0.36–0.83) | ||
Worries: May lead to pregnancy loss or stillbirth | 254 (35.5) | 197 (56.9) | 0.42 (0.32–0.54) | 1.07 (0.76–1.51) | ||
Worries: May lead to fetal growth and development problems | 326 (45.5) | 278 (80.4) | 0.20 (0.15–0.28) | 0.33 (0.22–0.50) | ||
Worries: Child behavioural neurodevelopmental problems | 244 (34.1) | 227 (65.6) | 0.27 (0.21–0.36) | 0.61 (0.43–0.86) | ||
Date of survey completion | 0.99 (0.98–0.99) | 0.99 (0.98–1.00) | ||||
D. Breastfeeding (n = 670) | Willing to be vaccinated | OR (95% CI) | aOR (95% CI) | |||
Yes = 560 | No = 110 | |||||
Variables | n (%) | n (%) | ||||
Spoken to HCP about vaccine during perinatal period | 184 (32.9) | 31 (28.2) | 1.25 (0.79–1.96) | 1.40 (0.82–2.40) | ||
Beliefs: I have a good understanding of how the COVID-19 vaccine works | 425 (75.9) | 61 (55.5) | 2.53 (1.66–3.86) | 1.01 (0.58–1.75) | ||
Beliefs: COVID-19 vaccine is effective | 493 (88.0) | 53 (48.2) | 7.91 (5.03–12.45) | 5.91 (3.43–10.19) | ||
Worries: May lead to infertility | 61 (10.9) | 49 (44.6) | 0.15 (0.10–0.24) | 0.44 (0.23–0.83) | ||
Worries: May lead to pregnancy loss or stillbirth | 50 (8.9) | 36 (32.7) | 0.20 (0.12–0.33) | 0.71 (0.34–1.47) | ||
Worries: May lead to fetal growth and development problems | 93 (16.6) | 60 (54.6) | 0.17 (0.11–0.26) | 0.51 (0.25–1.04) | ||
Worries: Child behavioural neurodevelopmental problems | 80 (14.3) | 51 (46.4) | 0.19 (0.13–0.30) | 0.60 (0.31–1.15) | ||
Date of survey completion | 0.98 (0.97–0.99) | 0.98 (0.97–0.99) |